HEADER TRANSCRIPTION 02-JUN-04 1TID TITLE CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS TITLE 2 ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA TITLE 3 SPOIIAA: POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM I COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-SIGMA F FACTOR; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: STAGE II SPORULATION PROTEIN AB; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ANTI-SIGMA F FACTOR ANTAGONIST; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: STAGE II SPORULATION PROTEIN AA; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 3 ORGANISM_TAXID: 1422; SOURCE 4 GENE: SPOIIAB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET21A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 12 ORGANISM_TAXID: 1422; SOURCE 13 GENE: SPOIIAA; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS SPOIIAB, SPOIIAA, ANTI-SIGMA, ANTI-ANTI-SIGMA, SPORULATION, SERINE KEYWDS 2 KINASE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGAN,F.LEON,S.A.DARST, AUTHOR 2 E.A.CAMPBELL REVDAT 6 15-NOV-23 1TID 1 REMARK REVDAT 5 23-AUG-23 1TID 1 REMARK REVDAT 4 27-OCT-21 1TID 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1TID 1 VERSN REVDAT 2 20-JUL-04 1TID 1 JRNL REVDAT 1 15-JUN-04 1TID 0 JRNL AUTH S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGIAN,F.LEON, JRNL AUTH 2 S.A.DARST,E.A.CAMPBELL JRNL TITL CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE JRNL TITL 2 BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE JRNL TITL 3 ANTI-ANTI-SIGMA SPOIIAA. JRNL REF J.MOL.BIOL. V. 340 941 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15236958 JRNL DOI 10.1016/J.JMB.2004.05.040 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 24765 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2236 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3889 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 1.504 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TID COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022662. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24765 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 18.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.19000 REMARK 200 FOR SHELL : 5.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY ID 1L0O, PDB ENTRY ID 1H4Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CHESS, 2-5% DMF, 2.0 M LITHIUM REMARK 280 SULFATE, PH 9.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 295.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 132.84600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 66.42300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 199.26900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY OF 2AB/ REMARK 300 2AA (A TETRAMER OF 2 HETERODIMERS) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE C 1 REMARK 465 ARG C 2 REMARK 465 GLY D -2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 125 CG CD OE1 OE2 REMARK 470 LYS A 128 CG CD CE NZ REMARK 470 SER B -1 OG REMARK 470 HIS B 0 CG ND1 CD2 CE1 NE2 REMARK 470 MSE B 1 CG SE CE REMARK 470 LYS C 41 CG CD CE NZ REMARK 470 GLU C 125 CG CD OE1 OE2 REMARK 470 LYS C 128 CG CD CE NZ REMARK 470 SER D -1 OG REMARK 470 HIS D 0 CG ND1 CD2 CE1 NE2 REMARK 470 MSE D 1 CG SE CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS B 0 O LEU B 3 1.55 REMARK 500 O MSE B 1 N LEU B 3 2.07 REMARK 500 OD1 ASN A 3 OG SER C 10 2.12 REMARK 500 O ILE A 52 O TYR A 56 2.16 REMARK 500 O MSE B 1 O LEU B 3 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS B 0 CA HIS B 0 CB 0.153 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 11 65.75 -68.15 REMARK 500 ASP A 31 56.22 38.27 REMARK 500 ASN A 58 -8.78 68.21 REMARK 500 ASP A 81 94.88 -179.36 REMARK 500 GLU A 82 39.31 -86.66 REMARK 500 LEU A 96 -8.43 74.64 REMARK 500 SER A 124 146.50 -179.04 REMARK 500 ASN A 127 -7.87 53.65 REMARK 500 LYS A 128 -63.29 -91.79 REMARK 500 HIS B 0 -12.79 95.54 REMARK 500 MSE B 1 -80.42 -54.55 REMARK 500 SER B 2 -6.02 -36.24 REMARK 500 ALA B 4 115.84 -173.09 REMARK 500 GLN B 11 -136.18 70.20 REMARK 500 ASP B 12 23.46 -71.85 REMARK 500 ASP B 23 -168.69 -127.11 REMARK 500 ASP B 57 -168.77 -120.12 REMARK 500 LYS B 98 -8.82 -57.89 REMARK 500 PHE C 9 148.01 -175.47 REMARK 500 ALA C 11 60.76 -68.96 REMARK 500 ASN C 58 27.32 46.86 REMARK 500 GLU C 82 60.76 -100.37 REMARK 500 VAL C 84 -29.97 -36.05 REMARK 500 PRO C 87 -78.94 -54.82 REMARK 500 LYS C 100 43.65 -140.66 REMARK 500 ASN C 127 -4.52 66.92 REMARK 500 GLN D 11 -135.32 70.44 REMARK 500 ASP D 12 23.28 -79.62 REMARK 500 ASP D 57 -165.83 -124.76 REMARK 500 GLU D 106 -10.30 -48.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 300 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 50 OD1 REMARK 620 2 ATP A 200 O1G 156.0 REMARK 620 3 ATP A 200 O1B 109.2 94.7 REMARK 620 4 ATP A 200 O3A 109.1 86.5 43.3 REMARK 620 5 ATP A 200 O1A 74.8 103.5 90.4 51.4 REMARK 620 6 HOH A 301 O 78.1 79.6 162.8 150.4 106.7 REMARK 620 7 HOH A 313 O 104.9 79.0 84.4 124.3 174.4 78.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN C 50 OD1 REMARK 620 2 ATP C 201 O1B 90.2 REMARK 620 3 ATP C 201 O1G 144.1 99.3 REMARK 620 4 ATP C 201 O2G 156.6 69.6 54.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP C 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1THN RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FORM I REMARK 900 RELATED ID: 1TH8 RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FORM II REMARK 900 RELATED ID: 1TIL RELATED DB: PDB REMARK 900 POISED FOR PHOSPHORYLATION COMPLEX , CRYSTAL FORM II REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE DISCREPANCIES IN BOTH CHAINS ARE DUE TO STRAIN REMARK 999 VARIATION. DBREF 1TID A 1 136 UNP O32727 SP2AB_BACST 1 136 DBREF 1TID B 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1TID C 1 136 UNP O32727 SP2AB_BACST 1 136 DBREF 1TID D 1 116 UNP O32726 SP2AA_BACST 1 116 SEQADV 1TID MSE A 1 UNP O32727 MET 1 MODIFIED RESIDUE SEQADV 1TID MSE A 5 UNP O32727 MET 5 MODIFIED RESIDUE SEQADV 1TID MSE A 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TID MSE A 108 UNP O32727 MET 108 MODIFIED RESIDUE SEQADV 1TID MSE A 113 UNP O32727 MET 113 MODIFIED RESIDUE SEQADV 1TID MSE A 117 UNP O32727 MET 117 MODIFIED RESIDUE SEQADV 1TID MSE C 1 UNP O32727 MET 1 MODIFIED RESIDUE SEQADV 1TID MSE C 5 UNP O32727 MET 5 MODIFIED RESIDUE SEQADV 1TID MSE C 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TID MSE C 108 UNP O32727 MET 108 MODIFIED RESIDUE SEQADV 1TID MSE C 113 UNP O32727 MET 113 MODIFIED RESIDUE SEQADV 1TID MSE C 117 UNP O32727 MET 117 MODIFIED RESIDUE SEQADV 1TID GLY B -2 UNP O32726 CLONING ARTIFACT SEQADV 1TID SER B -1 UNP O32726 CLONING ARTIFACT SEQADV 1TID HIS B 0 UNP O32726 CLONING ARTIFACT SEQADV 1TID MSE B 1 UNP O32726 MET 1 MODIFIED RESIDUE SEQADV 1TID VAL B 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TID GLU B 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TID LEU B 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TID ARG B 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TID GLU B 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TID GLN B 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TID VAL B 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TID THR B 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TID ASP B 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TID VAL B 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TID ASN B 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TID MSE B 56 UNP O32726 MET 56 MODIFIED RESIDUE SEQADV 1TID ALA B 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TID MSE B 78 UNP O32726 MET 78 MODIFIED RESIDUE SEQADV 1TID MSE B 93 UNP O32726 MET 93 MODIFIED RESIDUE SEQADV 1TID GLY D -2 UNP O32726 CLONING ARTIFACT SEQADV 1TID SER D -1 UNP O32726 CLONING ARTIFACT SEQADV 1TID HIS D 0 UNP O32726 CLONING ARTIFACT SEQADV 1TID MSE D 1 UNP O32726 MET 1 MODIFIED RESIDUE SEQADV 1TID VAL D 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TID GLU D 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TID LEU D 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TID ARG D 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TID GLU D 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TID GLN D 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TID VAL D 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TID THR D 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TID ASP D 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TID VAL D 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TID ASN D 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TID MSE D 56 UNP O32726 MET 56 MODIFIED RESIDUE SEQADV 1TID ALA D 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TID MSE D 78 UNP O32726 MET 78 MODIFIED RESIDUE SEQADV 1TID MSE D 93 UNP O32726 MET 93 MODIFIED RESIDUE SEQRES 1 A 136 MSE ARG ASN GLU MSE HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 A 136 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 A 136 VAL ALA GLN LEU ASP PRO THR MSE ASP GLU LEU THR GLU SEQRES 4 A 136 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 A 136 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 A 136 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 A 136 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 A 136 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 A 136 ARG SER GLY MSE GLY PHE THR ILE MSE GLU ASN PHE MSE SEQRES 10 A 136 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 A 136 THR VAL TYR LEU LYS LYS SEQRES 1 B 119 GLY SER HIS MSE SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 B 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 B 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 B 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 B 119 LEU GLY GLN LEU THR PHE MSE ASP ALA SER GLY LEU GLY SEQRES 6 B 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 B 119 GLY GLN MSE VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 B 119 ARG LEU PHE ASP MSE SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 B 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 B 119 VAL ALA SEQRES 1 C 136 MSE ARG ASN GLU MSE HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 C 136 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 C 136 VAL ALA GLN LEU ASP PRO THR MSE ASP GLU LEU THR GLU SEQRES 4 C 136 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 C 136 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 C 136 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 C 136 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 C 136 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 C 136 ARG SER GLY MSE GLY PHE THR ILE MSE GLU ASN PHE MSE SEQRES 10 C 136 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 C 136 THR VAL TYR LEU LYS LYS SEQRES 1 D 119 GLY SER HIS MSE SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 D 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 D 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 D 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 D 119 LEU GLY GLN LEU THR PHE MSE ASP ALA SER GLY LEU GLY SEQRES 6 D 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 D 119 GLY GLN MSE VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 D 119 ARG LEU PHE ASP MSE SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 D 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 D 119 VAL ALA MODRES 1TID MSE A 1 MET SELENOMETHIONINE MODRES 1TID MSE A 5 MET SELENOMETHIONINE MODRES 1TID MSE A 34 MET SELENOMETHIONINE MODRES 1TID MSE A 108 MET SELENOMETHIONINE MODRES 1TID MSE A 113 MET SELENOMETHIONINE MODRES 1TID MSE A 117 MET SELENOMETHIONINE MODRES 1TID MSE B 1 MET SELENOMETHIONINE MODRES 1TID MSE B 56 MET SELENOMETHIONINE MODRES 1TID MSE B 78 MET SELENOMETHIONINE MODRES 1TID MSE B 93 MET SELENOMETHIONINE MODRES 1TID MSE C 5 MET SELENOMETHIONINE MODRES 1TID MSE C 34 MET SELENOMETHIONINE MODRES 1TID MSE C 108 MET SELENOMETHIONINE MODRES 1TID MSE C 113 MET SELENOMETHIONINE MODRES 1TID MSE C 117 MET SELENOMETHIONINE MODRES 1TID MSE D 1 MET SELENOMETHIONINE MODRES 1TID MSE D 56 MET SELENOMETHIONINE MODRES 1TID MSE D 78 MET SELENOMETHIONINE MODRES 1TID MSE D 93 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 5 8 HET MSE A 34 8 HET MSE A 108 8 HET MSE A 113 8 HET MSE A 117 8 HET MSE B 1 5 HET MSE B 56 8 HET MSE B 78 8 HET MSE B 93 8 HET MSE C 5 8 HET MSE C 34 8 HET MSE C 108 8 HET MSE C 113 8 HET MSE C 117 8 HET MSE D 1 5 HET MSE D 56 8 HET MSE D 78 8 HET MSE D 93 8 HET MG A 300 1 HET ATP A 200 31 HET MG C 301 1 HET ATP C 201 31 HETNAM MSE SELENOMETHIONINE HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 1 MSE 19(C5 H11 N O2 SE) FORMUL 5 MG 2(MG 2+) FORMUL 6 ATP 2(C10 H16 N5 O13 P3) FORMUL 9 HOH *62(H2 O) HELIX 1 1 ARG A 12 ALA A 28 1 17 HELIX 2 2 GLN A 29 ASP A 31 5 3 HELIX 3 3 THR A 33 GLY A 55 1 23 HELIX 4 4 ASP A 88 ARG A 93 1 6 HELIX 5 5 MSE A 108 MSE A 117 1 10 HELIX 6 6 ASP B 23 ARG B 41 1 19 HELIX 7 7 ASP B 57 VAL B 74 1 18 HELIX 8 8 SER B 84 SER B 94 1 11 HELIX 9 9 GLY B 95 ILE B 99 5 5 HELIX 10 10 ASP B 105 LEU B 113 1 9 HELIX 11 11 ARG C 12 GLU C 14 5 3 HELIX 12 12 ASN C 15 ALA C 28 1 14 HELIX 13 13 GLN C 29 ASP C 31 5 3 HELIX 14 14 THR C 33 HIS C 54 1 22 HELIX 15 15 ASP C 88 ARG C 93 1 6 HELIX 16 16 LYS C 100 GLU C 104 5 5 HELIX 17 17 MSE C 108 MSE C 117 1 10 HELIX 18 18 ASP D 23 ARG D 41 1 19 HELIX 19 19 ASP D 57 ASN D 73 1 17 HELIX 20 20 SER D 84 SER D 94 1 11 HELIX 21 21 GLY D 95 ILE D 99 5 5 HELIX 22 22 ASP D 105 LEU D 113 1 9 SHEET 1 A10 GLU A 119 GLU A 125 0 SHEET 2 A10 GLY A 129 LYS A 136 -1 O TYR A 133 N ILE A 121 SHEET 3 A10 VAL A 74 VAL A 79 -1 N VAL A 75 O LYS A 136 SHEET 4 A10 ILE A 63 GLU A 71 -1 N GLU A 71 O VAL A 74 SHEET 5 A10 ARG A 2 SER A 10 -1 N LEU A 7 O ILE A 66 SHEET 6 A10 GLU C 4 SER C 10 -1 O HIS C 6 N GLN A 8 SHEET 7 A10 ILE C 63 GLU C 71 -1 O ILE C 66 N LEU C 7 SHEET 8 A10 VAL C 74 ASP C 81 -1 O ARG C 80 N SER C 65 SHEET 9 A10 GLY C 129 LYS C 136 -1 O THR C 130 N ASP C 81 SHEET 10 A10 GLU C 119 GLU C 125 -1 N ILE C 121 O TYR C 133 SHEET 1 B 5 ILE B 5 LYS B 10 0 SHEET 2 B 5 VAL B 13 LEU B 22 -1 O ILE B 15 N GLU B 8 SHEET 3 B 5 HIS B 45 MSE B 56 1 O VAL B 47 N VAL B 16 SHEET 4 B 5 MSE B 78 CYS B 81 1 O VAL B 79 N LEU B 48 SHEET 5 B 5 ARG B 101 GLU B 103 1 O ARG B 101 N VAL B 80 SHEET 1 C 5 LEU D 3 LYS D 10 0 SHEET 2 C 5 VAL D 13 LEU D 22 -1 O SER D 19 N ALA D 4 SHEET 3 C 5 HIS D 45 MSE D 56 1 O THR D 54 N GLY D 20 SHEET 4 C 5 MSE D 78 CYS D 81 1 O VAL D 79 N LEU D 48 SHEET 5 C 5 ARG D 101 GLU D 103 1 O GLU D 103 N VAL D 80 LINK C MSE A 1 N ARG A 2 1555 1555 1.33 LINK C GLU A 4 N MSE A 5 1555 1555 1.32 LINK C MSE A 5 N HIS A 6 1555 1555 1.33 LINK C THR A 33 N MSE A 34 1555 1555 1.33 LINK C MSE A 34 N ASP A 35 1555 1555 1.32 LINK C GLY A 107 N MSE A 108 1555 1555 1.33 LINK C MSE A 108 N GLY A 109 1555 1555 1.33 LINK C ILE A 112 N MSE A 113 1555 1555 1.33 LINK C MSE A 113 N GLU A 114 1555 1555 1.33 LINK C PHE A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N ASP A 118 1555 1555 1.33 LINK C HIS B 0 N MSE B 1 1555 1555 1.34 LINK C MSE B 1 N SER B 2 1555 1555 1.34 LINK C PHE B 55 N MSE B 56 1555 1555 1.33 LINK C MSE B 56 N ASP B 57 1555 1555 1.33 LINK C GLN B 77 N MSE B 78 1555 1555 1.32 LINK C MSE B 78 N VAL B 79 1555 1555 1.33 LINK C ASP B 92 N MSE B 93 1555 1555 1.33 LINK C MSE B 93 N SER B 94 1555 1555 1.33 LINK C GLU C 4 N MSE C 5 1555 1555 1.33 LINK C MSE C 5 N HIS C 6 1555 1555 1.33 LINK C THR C 33 N MSE C 34 1555 1555 1.33 LINK C MSE C 34 N ASP C 35 1555 1555 1.33 LINK C GLY C 107 N MSE C 108 1555 1555 1.33 LINK C MSE C 108 N GLY C 109 1555 1555 1.33 LINK C ILE C 112 N MSE C 113 1555 1555 1.34 LINK C MSE C 113 N GLU C 114 1555 1555 1.33 LINK C PHE C 116 N MSE C 117 1555 1555 1.34 LINK C MSE C 117 N ASP C 118 1555 1555 1.33 LINK C HIS D 0 N MSE D 1 1555 1555 1.33 LINK C MSE D 1 N SER D 2 1555 1555 1.33 LINK C PHE D 55 N MSE D 56 1555 1555 1.33 LINK C MSE D 56 N ASP D 57 1555 1555 1.33 LINK C GLN D 77 N MSE D 78 1555 1555 1.32 LINK C MSE D 78 N VAL D 79 1555 1555 1.33 LINK C ASP D 92 N MSE D 93 1555 1555 1.33 LINK C MSE D 93 N SER D 94 1555 1555 1.33 LINK OD1 ASN A 50 MG MG A 300 1555 1555 2.06 LINK O1G ATP A 200 MG MG A 300 1555 1555 2.50 LINK O1B ATP A 200 MG MG A 300 1555 1555 2.34 LINK O3A ATP A 200 MG MG A 300 1555 1555 3.12 LINK O1A ATP A 200 MG MG A 300 1555 1555 2.77 LINK MG MG A 300 O HOH A 301 1555 1555 2.22 LINK MG MG A 300 O HOH A 313 1555 1555 2.63 LINK OD1 ASN C 50 MG MG C 301 1555 1555 2.36 LINK O1B ATP C 201 MG MG C 301 1555 1555 2.39 LINK O1G ATP C 201 MG MG C 301 1555 1555 2.42 LINK O2G ATP C 201 MG MG C 301 1555 1555 2.91 SITE 1 AC1 4 ASN A 50 ATP A 200 HOH A 301 HOH A 313 SITE 1 AC2 2 ASN C 50 ATP C 201 SITE 1 AC3 26 GLU A 46 ASN A 50 ALA A 51 HIS A 54 SITE 2 AC3 26 ASP A 81 VAL A 84 GLY A 85 ILE A 86 SITE 3 AC3 26 ALA A 92 PHE A 97 THR A 98 THR A 99 SITE 4 AC3 26 ARG A 105 SER A 106 GLY A 107 MSE A 108 SITE 5 AC3 26 GLY A 109 PHE A 110 THR A 130 MG A 300 SITE 6 AC3 26 HOH A 301 HOH A 305 HOH A 312 HOH A 313 SITE 7 AC3 26 HOH A 314 ALA B 58 SITE 1 AC4 23 GLU C 46 ASN C 50 ALA C 51 HIS C 54 SITE 2 AC4 23 GLY C 55 ASP C 81 GLY C 85 ILE C 86 SITE 3 AC4 23 ALA C 92 PHE C 97 THR C 98 THR C 99 SITE 4 AC4 23 ARG C 105 SER C 106 GLY C 107 MSE C 108 SITE 5 AC4 23 GLY C 109 PHE C 110 MG C 301 HOH C 319 SITE 6 AC4 23 HOH C 320 ALA D 58 HOH D 119 CRYST1 49.465 49.465 265.692 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020216 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020216 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003764 0.00000 HETATM 1 N MSE A 1 80.975 -23.783 -65.732 1.00 74.31 N HETATM 2 CA MSE A 1 81.214 -22.444 -66.335 1.00 75.34 C HETATM 3 C MSE A 1 80.185 -21.457 -65.811 1.00 72.90 C HETATM 4 O MSE A 1 79.404 -21.796 -64.925 1.00 72.46 O HETATM 5 CB MSE A 1 81.138 -22.529 -67.860 1.00 79.94 C HETATM 6 CG MSE A 1 79.749 -22.746 -68.432 1.00 85.68 C HETATM 7 SE MSE A 1 79.856 -23.111 -70.340 1.00 95.47 SE HETATM 8 CE MSE A 1 80.319 -21.364 -71.005 1.00 91.94 C